Protein transduction: A novel tool for tissue regeneration

Biological Chemistry

Volumn 383, Issue 10, 2002, Pages 1593-1599

  Cardoso, M Cristina ^a   Leonhardt, Heinrich ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cell cycle reentry; Protein therapy; Retrodifferentiation; SV40 T antigen; TAT; VP22

Indexed keywords

CYTOSINE DEAMINASE; HOMEODOMAIN PROTEIN; PROTEIN P53; PROTEIN VP22; T LYMPHOCYTE ANTIGEN; THYMIDINE KINASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PHOSPHOPROTEIN; VIRUS PROTEIN; HYBRID PROTEIN; PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSDUCTION; GENETIC TRANSFORMATION; HEART; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; TISSUE REGENERATION; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

ANIMALIA; HERPES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

AMINO ACID SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; HUMANS; MODELS, BIOLOGICAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEINS; RECOMBINANT FUSION PROTEINS; REGENERATION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; VIRAL STRUCTURAL PROTEINS;

EID: 0036805434     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.180     Document Type: Article

References (46)

1. Aints, A., Guven, H., Gahrton, G., Smith, C. I., and Dilber, M. S. (2001). Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther. 8, 1051-1056.
2. Ali, S. H., and DeCaprio, J. A. (2001). Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin. Cancer Biol. 11, 15-23.
3. Berghella, L., De Angelis, L., Coletta, M., Berarducci, B., Sonnino, C., Salvatori, G., Anthonissen, C., Cooper, R., Butler-Browne, G. S., Mouly, V. et al. (1999). Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum. Gene Ther. 10, 1607-1617.
4. Brockes, J. P. (1997). Amphibian limb regeneration: rebuilding a complex structure. Science 276, 81-87.
5. Cardoso, M. C., and Leonhardt, H. (1999). Differentiation, development and programmed cell death. In: The Molecular Basis of Cell Cycle and Growth Control, G. Stein, R. Baserga, D. Denhardt, and A. Giordano, eds. (New York, USA: John Wiley & Sons), pp. 305-347.
6. Cardoso, M. C., Leonhardt, H., and Nadal-Ginard, B. (1993). Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979-992.
7. Derer, W., Easwaran, H. P., Knopf, C. W., Leonhardt, H., and Cardoso, M. C. (1999). Direct protein transfer to terminally differentiated muscle cells. J. Mol. Med. 77, 609-613.
8. Derer, W., Easwaran, H. P., Leonhardt, H., and Cardoso, M. C. (2002). A novel approach to induce cell cycle reentry in terminally differentiated muscle cells. FASEB J. 16, 132-133.
9. Dilber, M. S., Phelan, A., Aints, A., Mohamed, A. J., Elliott, G., Smith, C. I. E., and O'Hare, P. (1999). Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6, 12-21.
10. Elliott, G., and O'Hare, P. (1997). Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell 88, 223-233.
11. Elliott, G., and O'Hare, P. (2000). Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division. J. Virol. 74, 2131-2141.
12. Endo, T., and Nadal-Ginard, B. (1989). SV40 large T-antigen induces reentry of terminally differentiated myotubes into the cell cycle. In: The Cellular and Molecular Biology of Muscle Development, L. H. Kedes, and F. E. Stockdale, eds. (New York, USA: Alan R. Liss, Inc.), pp. 95-104.
13. Foddis, R., De Rienzo, A., Broccoli, D., Bocchetta, M., Stekala, E., Rizzo, P., Tosolini, A., Grobelny, J. V., Jhanwar, S. C., Pass, H. I. et al. (2002). SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 21, 1434-1442.
14. Ford, K. G., Souberbielle, B. E., Darling, D., and Farzaneh, F. (2001). Protein transduction: an alternative to genetic intervention? Gene Ther. 8, 1-4.
15. Frankel, A. D., and Pabo, C. O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
16. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
17. Green, M., and Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
18. Han, K., Jeon, M. J., Kim, S. H., Ki, D., Bahn, J. H., Lee, K. S., Park, J., and Choi, S. Y. (2001). Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol. Cells 12, 267-271.
19. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. F. (2001). Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
20. Jeang, K. T., Xiao, H., and Rich, E. A. (1999). Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274, 28837-28840.
21. Joliot, A., Pernelle, C., Deagostini-Bazin, H., and Prochiantz, A. (1991). Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA 88, 1864-1868.
22. Kobayashi, N., Fujiwara, T., Westerman, K. A., Inoue, Y., Sakaguchi, M., Noguchi, H., Miyazaki, M., Cai, J., Tanaka, N., Fox, I. J., and Leboulch, P. (2000). Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287, 1258-1262.
23. Li, L. P., Schlag, P. M., and Blankenstein, T. (1997). Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells. Hum. Gene Ther. 8, 1695-1700.
24. Liu, C. S., Kong, B., Xia, H. H., Ellem, K. A., and Wei, M. Q. (2001). VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J. Gene Med. 3, 145-152.
25. Mai, J. C., Shen, H., Watkins, S. C., Cheng, T., and Robbins, P. D. (2002). Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J. Biol. Chem. 28, 30208-30218.
26. Martin, A., O'Hare, P., McLauchlan, J., and Elliott, G. (2002). Herpes simplex virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding. J. Virol. 76, 4961-4970.
27. McGann, C. J., Odelberg, S. J., and Keating, M. T. (2001). Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc. Natl. Acad. Sci. USA 98, 13699-13704.
28. Mi, Z., Mai, J., Lu, X., and Robbins, P. D. (2000). Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2, 339-347.
29. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998). Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nature Med. 4, 1449-1452.
30. Normand, N., van Leeuwen, H., and O'Hare, P. (2001). Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem. 276, 15042-15050.
31. Obinata, M. (1997). Conditionally immortalized cell lines with differentiated functions established from temperature-sensitive T-antigen transgenic mice. Genes Cells 2, 235-244.
32. Park, J., Ryu, J., Jin, L. H., Bahn, J. H., Kim, J. A., Yoon, C. S., Kim, D. W., Han, K. H., Eum, W. S., Kwon, H. Y. et al. (2002). 9-polylysine protein transduction domain: enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol. Cells 13, 202-208.
33. Pearson, H. (2001). The regeneration gap. Nature 414, 388-390.
34. Phelan, A., Elliott, G., and O'Hare, P. (1998). Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nature Biotechnol. 16, 440-443.
35. Prochiantz, A. (1996). Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. 6, 629-634.
36. Prochiantz, A. (2000). Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12, 400-406.
37. Ren, X., Harms, J. S., and Splitter, G. A. (2001). Bovine herpesvirus 1 tegument protein VP22 interacts with histones, and the carboxyl terminus of VP22 is required for nuclear localization. J. Virol. 75, 8251-8258.
38. Theodore, L., Derossi, D., Chassaing, G., Llirbat, B., Kubes, M., Jordan, P., Chneiweiss, H., Godement, P., and Prochiantz, A. (1995). Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 15, 7158-7167.
39. Velloso, C. P., Simon, A., and Brockes, J. P. (2001). Mammalian postmitotic nuclei reenter the cell cycle after serum stimulation in newt/mouse hybrid myotubes. Curr. Biol. 11, 855-858.
40. Verma, I. M., and Somia, N. (1997). Gene therapy - promises, problems and prospects. Nature 389, 239-242.
41. Vives, E., Brodin, P., and Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
42. Wadia, J. S., and Dowdy, S. F. (2002). Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56.
43. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003-13008.
44. Wills, K. N., Atencio, I. A., Avanzini, J. B., Neuteboom, S., Phelan, A., Philopena, J., Sutjipto, S., Vaillancourt, M. T., Wen, S. F., Ralston, R. O., and Johnson, D. E. (2001). Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J. Virol. 75, 8733-8741.
45. Wybranietz, W. A., Gross, C. D., Phelan, A., O'Hare, P., Spiegel, M., Graeper, F., Bitzer, M., Stahler, P., Gregor, M., and Lauer, U. M. (2001). Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther. 8, 1654-1664.
46. Zender, L., Kuhnel, F., Kock, R., Manns, M., and Kubicka, S. (2002). VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo. Cancer Gene Ther. 9, 489-496.